Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence
- 30 November 1993
- Vol. 42 (5), 554-558
- https://doi.org/10.1016/0090-4295(93)90272-c
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Objective Double-Blind Evaluation of Erectile Function with Intracorporeal Papaverine in Combination with Phentolamine and/or Prostaglandin E1Journal of Urology, 1992
- Pharmacological Erection Program Using Prostaglandin E1Journal of Urology, 1991
- Intracavernous Self-Injection of Vasoactive Drugs in the Treatment of Impotence: 8-Year Experience with 615 CasesJournal of Urology, 1991
- Intracavernous Injection of Prostagland in E1 in combination With Papaverine: Enhanced Effectiveness in Comparison With Papaverine Plus Phentolamine and Prostaglandin E1 AloneJournal of Urology, 1991
- Prostaglandin E1 Versus Phentolamine/Papaverine for the Treatment of Erectile Impotence: A Double-Blind ComparisonJournal of Urology, 1989
- Intracavernous Injection of Prostaglandin E1 for the Treatment of Erectile ImpotenceJournal of Urology, 1989
- Systemic complication of intracavernous papaverine injection in patients with venous leakageUrology, 1988
- Nonoperative Management of ImpotenceJournal of Urology, 1988
- Physiology of Erection and Pharmacological Management of ImpotenceJournal of Urology, 1987
- Functional Evaluation of Penile Veins by cavernosography in Papaverine-Induced ErectionJournal of Urology, 1986